Diabetes is a serious global health issue, affecting not only Palau and Japan but also the world at large. Currently, there are approximately 537 million people with diabetes worldwide. This number is projected to rise to about 643 million by 2030 and 783 million by 2045. This means that over 1 in 10 adults globally may have diabetes, and in some countries, this could increase to 1 in 5. The ongoing rise in diabetes cases presents a significant challenge.
We aim to achieve a fundamental cure for diabetes. Conventional treatments primarily focus on managing blood glucose levels, without addressing the root cause of diabetes or its complications. Our innovative approach targets and removes specific cells that cause diabetes, offering a pathway to a potential cure.
A research team led by Professor Hideto Kojima has made groundbreaking discoveries showing that diabetes and its complications can be cured through targeted treatment. These findings, published in academic journals, highlight a significant breakthrough in achieving diabetes remission.
Research reveals that diabetes arises when high blood sugar disrupts hematopoietic stem cells in the bone marrow, leading to sustained abnormalities. To address this, specific drugs can be used to eliminate the abnormal cells, guiding patients toward recovery.
The persistent challenge in curing diabetes stems from high blood sugar causing abnormal HDAC expression in hematopoietic stem cells, which in turn impairs the function of multiple organs. HDAC inhibitors, a class of drugs, have proven effective in eliminating these abnormal cells, paving the way for diabetes treatment.
Palau Majesty Development Inc. supports development projects such as the construction of hotels and clinics for medical tourism.
For more details, please visit the Biozipcode, Inc. website.
